181 related articles for article (PubMed ID: 35903297)
21. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
[TBL] [Abstract][Full Text] [Related]
22. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling.
Han B; Zhang H; Tian R; Liu H; Wang Z; Wang Z; Tian J; Cui Y; Ren S; Zuo X; Tian R; Niu R; Zhang F
Theranostics; 2022; 12(9):4127-4146. PubMed ID: 35673569
[No Abstract] [Full Text] [Related]
23. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
[TBL] [Abstract][Full Text] [Related]
24. High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.
Lehtinen L; Ketola K; Mäkelä R; Mpindi JP; Viitala M; Kallioniemi O; Iljin K
Oncotarget; 2013 Jan; 4(1):48-63. PubMed ID: 23295955
[TBL] [Abstract][Full Text] [Related]
25. The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells.
Mendoza-Villanueva D; Deng W; Lopez-Camacho C; Shore P
Mol Cancer; 2010 Jun; 9():171. PubMed ID: 20591170
[TBL] [Abstract][Full Text] [Related]
26. Runx2 induces bone osteolysis by transcriptional suppression of TSSC1.
Wang DC; Wang HF; Yuan ZN
Biochem Biophys Res Commun; 2013 Sep; 438(4):635-9. PubMed ID: 23933319
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.
Capulli M; Angelucci A; Driouch K; Garcia T; Clement-Lacroix P; Martella F; Ventura L; Bologna M; Flamini S; Moreschini O; Lidereau R; Ricevuto E; Muraca M; Teti A; Rucci N
J Bone Miner Res; 2012 Nov; 27(11):2387-98. PubMed ID: 22714395
[TBL] [Abstract][Full Text] [Related]
28. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3.
Sun H; Wang C; Hu B; Gao X; Zou T; Luo Q; Chen M; Fu Y; Sheng Y; Zhang K; Zheng Y; Ren X; Yan S; Geng Y; Yang L; Dong Q; Qin L
Signal Transduct Target Ther; 2021 May; 6(1):187. PubMed ID: 34035222
[TBL] [Abstract][Full Text] [Related]
29. Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer.
Malik N; Kim YI; Yan H; Tseng YC; du Bois W; Ayaz G; Tran AD; Vera-Ramirez L; Yang H; Michalowski AM; Kruhlak M; Lee M; Hunter KW; Huang J
Cancer Res; 2023 Apr; 83(8):1280-1298. PubMed ID: 36799863
[TBL] [Abstract][Full Text] [Related]
30. Cbf beta regulates Runx2 function isoform-dependently in postnatal bone development.
Kanatani N; Fujita T; Fukuyama R; Liu W; Yoshida CA; Moriishi T; Yamana K; Miyazaki T; Toyosawa S; Komori T
Dev Biol; 2006 Aug; 296(1):48-61. PubMed ID: 16797526
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of a metastatic hybrid cell line generated by ER negative and ER positive breast cancer cells in mouse bone marrow.
Mukhopadhyay KD; Bandyopadhyay A; Chang TT; Elkahloun AG; Cornell JE; Yang J; Goins BA; Yeh IT; Sun LZ
PLoS One; 2011; 6(6):e20473. PubMed ID: 21673810
[TBL] [Abstract][Full Text] [Related]
32. Cbfb regulates bone development by stabilizing Runx family proteins.
Qin X; Jiang Q; Matsuo Y; Kawane T; Komori H; Moriishi T; Taniuchi I; Ito K; Kawai Y; Rokutanda S; Izumi S; Komori T
J Bone Miner Res; 2015 Apr; 30(4):706-14. PubMed ID: 25262822
[TBL] [Abstract][Full Text] [Related]
33. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
34. The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
Guo L; Chen B; Zhang G; Wang Y; Cao L; Ren C; Wen L; Lin J; Wei G; Liao N
Gene; 2020 Oct; 759():144970. PubMed ID: 32711101
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone-related protein and bone metastases.
Guise TA
Cancer; 1997 Oct; 80(8 Suppl):1572-80. PubMed ID: 9362424
[TBL] [Abstract][Full Text] [Related]
36. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype.
Sung V; Gilles C; Murray A; Clarke R; Aaron AD; Azumi N; Thompson EW
Exp Cell Res; 1998 Jun; 241(2):273-84. PubMed ID: 9637769
[TBL] [Abstract][Full Text] [Related]
37. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
38. The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription.
Malik N; Yan H; Moshkovich N; Palangat M; Yang H; Sanchez V; Cai Z; Peat TJ; Jiang S; Liu C; Lee M; Mock BA; Yuspa SH; Larson D; Wakefield LM; Huang J
Nat Commun; 2019 May; 10(1):2071. PubMed ID: 31061501
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
40. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.
Zong JC; Wang X; Zhou X; Wang C; Chen L; Yin LJ; He BC; Deng ZL
Oncol Rep; 2016 Feb; 35(2):739-48. PubMed ID: 26573960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
